Kateric

Since 2004, Kateric has been partnering with global biopharmaceutical companies to provide individualized, single source solutions for the preparation of a wide array of regulatory documents. Katerics core service areas include: Regulatory writing and editing of a wide range of products (biopharmaceutical, device, and diagnostics) and document types (e.g., clinical, nonclinical, and safety) across a variety of therapy areas . Quality control review of regulatory documents Clinical trials disclosure (CTD) and transparency services including but not limited to management consultation, clinical trial registry authoring (protocol registration and results disclosure) and maintenance, document redaction, plain language summaries, and end-to-end CTD services...

Document redaction,clinical trials disclosure,medical writing & editing,quality control review,and regulatory writing & editing

Kateric operates in the Writing and editing industry.

Kateric's revenue is 11m - 100m

Kateric has 11 - 50 employees.